New research suggests that people who lost substantial weight while taking popular GLP-1 medications like Ozempic, Wegovy, Mounjaro, or Saxenda experienced major health benefits beyond weight reduction alone. Patients who successfully lost weight showed significantly lower risks of obesity-related conditions such as sleep apnea, kidney disease, and other metabolic complications.
In contrast, people who gained weight while using these medications faced increased health risks – particularly for heart failure. Researchers also noted that many patients stopped taking the drugs within a year, highlighting the challenge of maintaining long-term treatment. The findings reinforce how sustained weight loss may dramatically improve overall health and reduce serious disease risk.
Read more at ScienceDaily
